Adoptive immunotherapy for patients with chronic lymphocytic leukaemia using a chimeric antigen receptor targeting CD23

被引：0
|
作者：
Raj, D. [1 ]
Peggs, K. [1 ]
Pule, M. [1 ]
Linch, D. [1 ]
Davies, M. [1 ]
Nathwani, A. [1 ]
机构：
[1] UCL, Dept Haematol, London WC1E 6BT, England
来源：
HUMAN GENE THERAPY | 2011年 / 22卷 / 10期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：A120 / A121
页数：2
相关论文
共 50 条
  • [31] Regulation of CD23 isoforms on B-chronic lymphocytic leukemia
    Goller, ME
    Kneitz, C
    Mehringer, C
    Müller, K
    Jelley-Gibbs, DM
    Gosselin, EJ
    Wilhelm, M
    Tony, HP
    LEUKEMIA RESEARCH, 2002, 26 (09) : 795 - 802
  • [32] CLINICAL MANUFACTURING OF CHIMERIC ANTIGEN RECEPTOR (CAR) T CELLS FOR ADOPTIVE IMMUNOTHERAPY
    Molgaard, K.
    Met, O.
    Svane, I. M.
    HUMAN GENE THERAPY, 2018, 29 (11) : A17 - A17
  • [33] Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
    Huan Shi
    Meili Sun
    Lin Liu
    Zhehai Wang
    Molecular Cancer, 13
  • [34] Chimeric antigen receptor for adoptive immunotherapy of cancer: latest research and future prospects
    Shi, Huan
    Sun, Meili
    Liu, Lin
    Wang, Zhehai
    MOLECULAR CANCER, 2014, 13
  • [35] Chimeric antigen receptor macrophages (CARMA) for adoptive cellular immunotherapy of solid tumors
    Klichinsky, Michael
    Ruella, Marco
    Shestova, Olga
    Kenderian, Saad S.
    Kim, Miriam Y.
    O'Connor, Roddy
    Scholler, John
    June, Carl
    Gill, Saar
    CANCER RESEARCH, 2017, 77
  • [36] Chimeric Antigen Receptor Engineering: A Right Step in the Evolution of Adoptive Cellular Immunotherapy
    Figueroa, Jose A.
    Reidy, Adair
    Mirandola, Leonardo
    Trotter, Kayley
    Suvorava, Natallia
    Figueroa, Alejandro
    Konala, Venu
    Aulakh, Amardeep
    Littlefield, Lauren
    Grizzi, Fabio
    Rahman, Rakhshanda Layeequr
    Jenkins, Marjorie R.
    Musgrove, Breeanna
    Radhi, Saba
    D'Cunha, Nicholas
    D'Cunha, Luke N.
    Hermonat, Paul L.
    Cobos, Everardo
    Chiriva-Internati, Maurizio
    INTERNATIONAL REVIEWS OF IMMUNOLOGY, 2015, 34 (02) : 154 - 187
  • [37] Adoptive T cell immunotherapy using chimeric antigen receptor against a novel cancer target Axl
    Intisar, Ejaj
    Walsh, Anthony
    Weinberg, Benjamin
    Chakravarti, Deboki
    Wong, Wilson
    JOURNAL OF IMMUNOLOGY, 2014, 192
  • [38] Idelalisib for optimized CD19-specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients
    Stock, Sophia
    Uebelhart, Rudolf
    Schubert, Maria-Luisa
    Fan, Fuli
    He, Bailin
    Hoffmann, Jean-Marc
    Wang, Lei
    Wang, Sanmei
    Gong, Wenjie
    Neuber, Brigitte
    Hueckelhoven-Krauss, Angela
    Gern, Ulrike
    Christ, Christiane
    Hexel, Monika
    Schmitt, Anita
    Schmidt, Patrick
    Krauss, Juergen
    Jaeger, Dirk
    Mueller-Tidow, Carsten
    Dreger, Peter
    Schmitt, Michael
    Sellner, Leopold
    INTERNATIONAL JOURNAL OF CANCER, 2019, 145 (05) : 1312 - 1324
  • [39] Accelerating chimeric antigen receptor therapy in chronic lymphocytic leukemia: The development and challenges of chimeric antigen receptor T-cell therapy for chronic lymphocytic leukemia
    Bair, Steven M.
    Porter, David L.
    AMERICAN JOURNAL OF HEMATOLOGY, 2019, 94 : S10 - S17
  • [40] Generation and optimization of a chimeric antigen receptor against human CD22: A new immunotherapeutic agent for adoptive immunotherapy
    Haso, Waleed
    Lee, Daniel
    Morgan, Richard
    Pastan, Ira
    Mackall, Crystal
    Orentas, Rimas J.
    CANCER RESEARCH, 2012, 72
12345